Skip to main content

Table 5 Postoperative outcomes

From: Prosthesis-patient mismatch after mitral valve replacement: a single-centered retrospective analysis in East China

 

total

PPM group

non-PPM group

P

Perioperative transfusion

269(25.2%)

47(24.9%)

222(25.3%)

NS

Ventilation time (hr)

21(20–23)

21(20–23)

21(20–23)

NS

Reintubation

3(0.3%)

0(0.0%)

3(0.3%)

NS

Duration of first time ICU

72(72–96)

72(72–96)

72(72–96)

NS

Reentering ICU

2(0.2%)

2(1.1%)

0(0.0%)

NS

Chest tube output (ml)

545.88 ± 365.82

555.15 ± 295.51

543.87 ± 379.47

NS

Reoperation for bleeding

18(1.7%)

1(0.5%)

17(1.9%)

NS

Sternal wound infection

3(0.3%)

0(0.0%)

3(0.3%)

NS

Cerebral infarction

5(0.5%)

0(0.0%)

5(0.6%)

NS

Postoperative stroke

1(0.1%)

0(0.0%)

1(0.1%)

NS

Newly onset AF

3(0.3%)

0(0.0%)

3(0.3%)

NS

Mortality within 30 days

9(0.8%)

2(1.1%)

7(0.8%)

NS

Hospitalization expense (USD)

13,726

(11632–16,030)

14,446

(12538–17,010)

13,628

(11509–15,775)

0.032

Length of stay (d)

14(12–18)

15(13–19)

14(12–18)

0.011

  1. ICU intensive care unit, AF atrial fibrillation, NS not significant